Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation.
Open Access
- 28 February 1989
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 83 (3) , 927-936
- https://doi.org/10.1172/jci113978
Abstract
Hypoxia in isolated myocytes results in accumulation of long-chain acylcarnitines (LCA) in sarcolemma. Inhibition of carnitine acyltransferase I (CAT-I) with sodium 2-[5-(4-chlorophenyl)-pentyl]-oxirane-2-carboxylate (POCA) prevents both the accumulation of LCA in the sarcolemma and the initial electrophysiologic derangements associated with hypoxia. Another amphiphilic metabolite, lysophosphatidylcholine (LPC), accumulates in the ischemic heart in vivo, in part because of inhibition of its catabolism by accumulating LCA. It induces electrophysiologic alterations in vitro analogous to early changes induced by ischemia in vivo. The present study was performed to determine whether POCA could prevent accumulation of both LCA and LPC induced by ischemia in vivo and if so, whether attenuation of early arrhythmogenesis would result. LAD coronary artery occlusions were induced for 5 min in chloralose-anesthetized cats. Coronary occlusion in untreated control animals elicited prompt, threefold increases of LCA (73 +/- 8 to 286 +/- 60 pmol/mg protein) and twofold increase of LPC (3.3 +/- 0.4 to 7.5 +/- 0.9 nmol/mg protein) selectively in the ischemic zone, associated with ventricular tachycardia (VT) or ventricular fibrillation (VF) occurring within the 5-min interval before acquisition of myocardial samples in 64% of the animals. POCA prevented the increase of both LCA and LPC. It also prevented the early occurrence of VT or VF (within 5 min of occlusion) in all animals studied. The antiarrhythmic effect of POCA was not attributable to favorable hemodynamic changes or to changes in myocardial perfusion measured with radiolabeled microspheres. Thus, inhibition of CAT-I effectively reduced the incidence of lethal arrhythmias induced early after the onset of ischemia. Accordingly, pharmacologic inhibition of this enzyme provides a promising approach for prophylaxis of sudden cardiac death, that typically occurs very soon after the onset of acute ischemia, in man.This publication has 45 references indexed in Scilit:
- Alpha1 adrenoceptors in the ischaemic and reperfused myocardiumJournal of Molecular and Cellular Cardiology, 1988
- Lysophosphoglycerides and ventricular fibrillation early after onset of ischemiaJournal of Molecular and Cellular Cardiology, 1987
- Electrophysiologic effects of intracellular lysophosphoglycerides and their accumulation in cardiac lymph with myocardial ischemia in dogs.Journal of Clinical Investigation, 1986
- Effects of POCA on metabolism and function in the ischemic rat heartBasic Research in Cardiology, 1986
- Effects of the Acylcarnitine-Transferase Blocking Agent Sodium 2[5-(4-Chlorophenyl)-Pentyl]-Oxirane-2-Carboxylate (POCA) on Metabolism and Regional Function in the Underperfused Canine MyocardiumJournal of Cardiovascular Pharmacology, 1985
- Decrease of fatty acid oxidation, ketogenesis and gluconeogenesis in isolated perfused rat liver by phenylalkyl oxirane carboxylate (B 807‐27) due to inhibition of CPT I (EC 2.3.1.21)European Journal of Biochemistry, 1985
- Effects of 2[5(4-chlorophenyl)pentyl]oxirane-2-carboxylate on fatty acid and glucose metabolism in perfused rat hearts determined using iodine-125 16-iodohexadecanoateBiochemical and Biophysical Research Communications, 1983
- Blood flow measurements with radionuclide-labeled particlesProgress in Cardiovascular Diseases, 1977
- The lipid composition of mitochondrial and microsomal fractions of rat myocardial homogenatesCardiovascular Research, 1970
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959